PDB Short entry for 2A45 HEADER HYDROLASE/HYDROLASE INHIBITOR 27-JUN-05 2A45 TITLE CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THROMBIN AND THE CENTRAL "E" TITLE 2 REGION OF FIBRIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN LIGHT CHAIN; COMPND 3 CHAIN: A, D; COMPND 4 SYNONYM: COAGULATION FACTOR II; COMPND 5 EC: 3.4.21.5; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: THROMBIN HEAVY CHAIN; COMPND 8 CHAIN: B, E; COMPND 9 SYNONYM: COAGULATION FACTOR II; COMPND 10 EC: 3.4.21.5; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: FIBRINOGEN ALPHA CHAIN; COMPND 13 CHAIN: G, J; COMPND 14 FRAGMENT: UNP P02671, RESIDUES 36-92; COMPND 15 MOL_ID: 4; COMPND 16 MOLECULE: FIBRINOGEN BETA CHAIN; COMPND 17 CHAIN: H, K; COMPND 18 MOL_ID: 5; COMPND 19 MOLECULE: FIBRINOGEN GAMMA CHAIN; COMPND 20 CHAIN: I, L SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 7 ORGANISM_COMMON: HUMAN; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 MOL_ID: 3; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 OTHER_DETAILS: PROTEOLYTIC FRAGMENT; SOURCE 14 MOL_ID: 4; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_COMMON: HUMAN; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 OTHER_DETAILS: PROTEOLYTIC FRAGMENT; SOURCE 19 MOL_ID: 5; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 OTHER_DETAILS: PROTEOLYTIC FRAGMENT KEYWDS THROMBIN, FIBRIN, FRAGMENT E, THROMBIN-FIBRIN COMPLEX, COILED COILS, KEYWDS 2 DISULFIDE RINGS, BLOOD CLOTTING, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.PECHIK,J.MADRAZO,G.L.GILLILAND,L.MEDVED REVDAT 7 23-AUG-23 2A45 1 REMARK LINK REVDAT 6 14-AUG-19 2A45 1 REMARK REVDAT 5 24-JUL-19 2A45 1 REMARK LINK REVDAT 4 11-OCT-17 2A45 1 REMARK REVDAT 3 13-JUL-11 2A45 1 VERSN REVDAT 2 24-FEB-09 2A45 1 VERSN REVDAT 1 02-MAY-06 2A45 0 SPRSDE 02-MAY-06 2A45 1QVH JRNL AUTH I.PECHIK,S.YAKOVLEV,M.W.MOSESSON,G.L.GILLILAND,L.MEDVED JRNL TITL STRUCTURAL BASIS FOR SEQUENTIAL CLEAVAGE OF FIBRINOPEPTIDES JRNL TITL 2 UPON FIBRIN ASSEMBLY. JRNL REF BIOCHEMISTRY V. 45 3588 2006 JRNL REFN ISSN 0006-2960 JRNL PMID 16533041 JRNL DOI 10.1021/BI0525369 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH I.PECHIK,J.MADRAZO,M.W.MOSESSON,I.HERNANDEZ,G.L.GILLILAND, REMARK 1 AUTH 2 L.MEDVED REMARK 1 TITL CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THROMBIN AND THE REMARK 1 TITL 2 CENTRAL "E" REGION OF FIBRIN REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 101 2718 2004 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 14978285 REMARK 1 DOI 10.1073/PNAS.0303440101 REMARK 2 REMARK 2 RESOLUTION. 3.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.4 REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.600 REMARK 3 FREE R VALUE TEST SET COUNT : 2390 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6834 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DIFFRACTION DATA WERE COLLECTED FROM REMARK 3 MEROHEDRALLY TWINNED CRYSTAL. THE PRESENCE OF 38.2% TWIN REMARK 3 FRACTION CORRESPONDING TO -H -H-K -L TWINNING OPERATOR WAS TAKEN REMARK 3 INTO ACCOUNT IN THE REFINEMENT.RESIDUES THAT ADDED THROUGH THE REMARK 3 MODELING EFFORTS (26 THROUGH 28, CHAINS G, J) ARE INCLUDED IN REMARK 3 THE COORDINATES FOR COMPLETENESS. THEY HAVE BEEN ASSIGNED REMARK 3 OCCUPANCIES AND TEMPERATURE FACTORS OF 0.0, AND THEY HAVE NO REMARK 3 VISIBLE/INTERPRETABLE ELECTRON DENSITY ASSOCIATED WITH THEIR REMARK 3 LOCATIONS. REMARK 4 REMARK 4 2A45 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUL-05. REMARK 100 THE DEPOSITION ID IS D_1000033464. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.90 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : SIEMENS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : COLLIMATOR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26890 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.650 REMARK 200 RESOLUTION RANGE LOW (A) : 31.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 3.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS 1.1 REMARK 200 STARTING MODEL: PDB ENTRIES 1PPB, 1JY2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3500, AMMONIUM PHOSPHATE, TRIS, PH REMARK 280 7.90, MICRODIALYSIS, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.15067 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 128.30133 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DECAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, E, G, H, I, J, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 1H REMARK 465 PHE A 1G REMARK 465 GLY A 1F REMARK 465 SER A 1E REMARK 465 GLU B 247 REMARK 465 THR D 1H REMARK 465 PHE D 1G REMARK 465 GLY D 1F REMARK 465 SER D 1E REMARK 465 GLU E 247 REMARK 465 GLY G 17 REMARK 465 PRO G 18 REMARK 465 ARG G 19 REMARK 465 VAL G 20 REMARK 465 VAL G 21 REMARK 465 GLU G 22 REMARK 465 ARG G 23 REMARK 465 HIS G 24 REMARK 465 GLN G 25 REMARK 465 GLY H 15 REMARK 465 HIS H 16 REMARK 465 ARG H 17 REMARK 465 PRO H 18 REMARK 465 LEU H 19 REMARK 465 ASP H 20 REMARK 465 LYS H 21 REMARK 465 LYS H 22 REMARK 465 ARG H 23 REMARK 465 GLU H 24 REMARK 465 GLU H 25 REMARK 465 ALA H 26 REMARK 465 PRO H 27 REMARK 465 SER H 28 REMARK 465 LEU H 29 REMARK 465 ARG H 30 REMARK 465 PRO H 31 REMARK 465 ALA H 32 REMARK 465 PRO H 33 REMARK 465 PRO H 34 REMARK 465 PRO H 35 REMARK 465 ILE H 36 REMARK 465 SER H 37 REMARK 465 GLY H 38 REMARK 465 GLY H 39 REMARK 465 GLY H 40 REMARK 465 TYR H 41 REMARK 465 ARG H 42 REMARK 465 ALA H 43 REMARK 465 ARG H 44 REMARK 465 PRO H 45 REMARK 465 ALA H 46 REMARK 465 LYS H 47 REMARK 465 ALA H 48 REMARK 465 ALA H 49 REMARK 465 ALA H 50 REMARK 465 THR H 51 REMARK 465 GLN H 52 REMARK 465 LYS H 53 REMARK 465 TYR I 1 REMARK 465 VAL I 2 REMARK 465 ALA I 3 REMARK 465 THR I 4 REMARK 465 ARG I 5 REMARK 465 GLY J 17 REMARK 465 PRO J 18 REMARK 465 ARG J 19 REMARK 465 VAL J 20 REMARK 465 VAL J 21 REMARK 465 GLU J 22 REMARK 465 ARG J 23 REMARK 465 HIS J 24 REMARK 465 GLN J 25 REMARK 465 GLY K 15 REMARK 465 HIS K 16 REMARK 465 ARG K 17 REMARK 465 PRO K 18 REMARK 465 LEU K 19 REMARK 465 ASP K 20 REMARK 465 LYS K 21 REMARK 465 LYS K 22 REMARK 465 ARG K 23 REMARK 465 GLU K 24 REMARK 465 GLU K 25 REMARK 465 ALA K 26 REMARK 465 PRO K 27 REMARK 465 SER K 28 REMARK 465 LEU K 29 REMARK 465 ARG K 30 REMARK 465 PRO K 31 REMARK 465 ALA K 32 REMARK 465 PRO K 33 REMARK 465 PRO K 34 REMARK 465 PRO K 35 REMARK 465 ILE K 36 REMARK 465 SER K 37 REMARK 465 GLY K 38 REMARK 465 GLY K 39 REMARK 465 GLY K 40 REMARK 465 TYR K 41 REMARK 465 ARG K 42 REMARK 465 ALA K 43 REMARK 465 ARG K 44 REMARK 465 PRO K 45 REMARK 465 ALA K 46 REMARK 465 LYS K 47 REMARK 465 ALA K 48 REMARK 465 ALA K 49 REMARK 465 ALA K 50 REMARK 465 THR K 51 REMARK 465 GLN K 52 REMARK 465 LYS K 53 REMARK 465 TYR L 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS B 36 CG CD CE NZ REMARK 470 LYS B 109 CG CD CE NZ REMARK 470 ARG B 126 CG CD NE CZ NH1 NH2 REMARK 470 LYS E 36 CG CD CE NZ REMARK 470 LYS E 109 CG CD CE NZ REMARK 470 ARG E 126 CG CD NE CZ NH1 NH2 REMARK 470 LEU G 73 CG CD1 CD2 REMARK 470 GLU H 84 CG CD OE1 OE2 REMARK 470 GLN H 88 CG CD OE1 NE2 REMARK 470 LEU H 100 CG CD1 CD2 REMARK 470 LYS I 35 CG CD CE NZ REMARK 470 LEU J 73 CG CD1 CD2 REMARK 470 GLU K 84 CG CD OE1 OE2 REMARK 470 GLN K 88 CG CD OE1 NE2 REMARK 470 LEU K 100 CG CD1 CD2 REMARK 470 LYS L 35 CG CD CE NZ REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 SER G 26 REMARK 475 ALA G 27 REMARK 475 CYS G 28 REMARK 475 SER J 26 REMARK 475 ALA J 27 REMARK 475 CYS J 28 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LYS I 35 OD2 ASP I 39 2.01 REMARK 500 OG SER B 195 O2 0G6 B 1 2.10 REMARK 500 OG SER E 195 O2 0G6 E 1 2.14 REMARK 500 O VAL H 97 ND2 ASN H 101 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER B 36A CB SER B 36A OG 0.085 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS E 168 CA - CB - SG ANGL. DEV. = 6.9 DEGREES REMARK 500 CYS G 28 CA - CB - SG ANGL. DEV. = -13.1 DEGREES REMARK 500 CYS G 28 N - CA - C ANGL. DEV. = 17.9 DEGREES REMARK 500 CYS H 80 CA - CB - SG ANGL. DEV. = 7.0 DEGREES REMARK 500 CYS J 28 CA - CB - SG ANGL. DEV. = -13.5 DEGREES REMARK 500 CYS J 28 N - CA - C ANGL. DEV. = 19.6 DEGREES REMARK 500 PRO J 46 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 1C -172.50 -50.13 REMARK 500 ASP A 1A -3.90 -160.76 REMARK 500 CYS A 1 -154.88 -64.14 REMARK 500 PHE A 7 -79.78 -155.44 REMARK 500 SER A 11 102.23 53.24 REMARK 500 LEU A 12 159.45 165.92 REMARK 500 LYS A 14A -35.67 -28.98 REMARK 500 THR A 14B 50.44 -145.27 REMARK 500 ILE A 14K -72.07 67.23 REMARK 500 ASP B 21 85.47 -56.42 REMARK 500 ALA B 22 155.55 -46.28 REMARK 500 GLN B 30 87.73 -64.74 REMARK 500 CYS B 42 -157.13 -148.31 REMARK 500 SER B 48 148.39 173.39 REMARK 500 ASP B 49 -3.79 -57.16 REMARK 500 ARG B 50 -6.30 -140.49 REMARK 500 ASP B 60E 99.09 36.67 REMARK 500 HIS B 71 -61.77 -125.33 REMARK 500 THR B 74 -82.39 -119.19 REMARK 500 ARG B 77A 124.82 -36.03 REMARK 500 ASN B 78 -7.84 69.77 REMARK 500 GLU B 86 -89.43 -114.52 REMARK 500 ASN B 98 21.52 -174.87 REMARK 500 LEU B 99 41.89 71.15 REMARK 500 ASP B 102 96.49 -65.84 REMARK 500 ILE B 103 136.54 -172.71 REMARK 500 PRO B 111 170.17 -43.49 REMARK 500 SER B 115 -147.58 -133.72 REMARK 500 HIS B 119 132.50 -178.81 REMARK 500 GLU B 127 -89.88 -49.22 REMARK 500 THR B 128 -33.73 -32.51 REMARK 500 ALA B 129 -109.39 -40.97 REMARK 500 ALA B 132 157.86 -43.44 REMARK 500 ASN B 143 -158.22 -66.28 REMARK 500 LEU B 144 67.03 174.32 REMARK 500 LYS B 145 169.43 150.59 REMARK 500 THR B 147 -86.15 -5.79 REMARK 500 THR B 149 -166.21 -127.62 REMARK 500 ASN B 149B 121.76 -173.77 REMARK 500 LEU B 155 135.04 -31.97 REMARK 500 ARG B 175 103.11 -55.78 REMARK 500 PHE B 181 132.97 179.66 REMARK 500 ALA B 183 126.12 162.72 REMARK 500 LYS B 186D 92.36 -168.43 REMARK 500 ARG B 187 -164.44 -66.32 REMARK 500 ASP B 189 164.43 178.08 REMARK 500 GLU B 192 119.81 -38.36 REMARK 500 PHE B 204A -72.92 -43.26 REMARK 500 ASN B 205 19.61 44.45 REMARK 500 VAL B 213 93.78 -40.26 REMARK 500 REMARK 500 THIS ENTRY HAS 170 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR L 32 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE INHIBITOR IS COVALENTLY CONNECTED TO ACTIVE_SITE REMARK 600 RESIDUES: REMARK 600 1) VIA A HEMIKETAL GROUP TO OG SER 195 IN CHAINS B AND E, REMARK 600 2) VIA A METHYLENE GROUP TO NE2 HIS 57 IN CHAINS B AND E. REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: D-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO)METHYL] REMARK 630 AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L-PROLINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0G6 B 1 REMARK 630 0G6 E 1 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: DPN PRO AR7 0QE REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0G6 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0G6 E 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 248 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 E 2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 HUMAN ALPHA THROMBIN COMPRISES AMINO ACID RESIDUES 1H TO 247 REMARK 999 (CHYMOTRYPSIN NUMBERING). N-TERMINAL SEQUENCES OF THE REMARK 999 CENTRAL "E" REGION OF HUMAN FIBRIN START FROM RESIDUE 17 REMARK 999 FOR ALPHA CHAINS (CHAINS G, J), 15 FOR BETA CHAINS (CHAINS REMARK 999 H, K), AND 1 FOR GAMMA CHAINS (CHAINS I, L). C-TERMINAL REMARK 999 SEQUENCES OF ALPHA, BETA, AND GAMMA CHAINS WERE NOT REMARK 999 DETERMINED. DUE TO THE LACK OF ELECTRON DENSITY THROMBIN REMARK 999 RESIDUES 1H THROUGH 1E AND RESIDUE 247 COULD NOT BE BUILD, REMARK 999 AS WELL AS RESIDUES 17 THROUGH 28 OF FIBRIN ALPHA CHAINS, REMARK 999 15 THROUGH 53 OF FIBRIN BETA CHAINS, AND 1 THROUGH 5 OF REMARK 999 FIBRIN GAMMA CHAINS. DBREF 2A45 A 1H 15 UNP P00734 THRB_HUMAN 328 363 DBREF 2A45 D 1H 15 UNP P00734 THRB_HUMAN 328 363 DBREF 2A45 B 16 247 UNP P00734 THRB_HUMAN 364 622 DBREF 2A45 E 16 247 UNP P00734 THRB_HUMAN 364 622 DBREF 2A45 G 17 73 UNP P02671 FIBA_HUMAN 36 92 DBREF 2A45 J 17 73 UNP P02671 FIBA_HUMAN 36 92 DBREF 2A45 H 15 105 UNP P02675 FIBB_HUMAN 45 135 DBREF 2A45 K 15 105 UNP P02675 FIBB_HUMAN 45 135 DBREF 2A45 I 1 45 UNP P02679 FIBG_HUMAN 27 71 DBREF 2A45 L 1 45 UNP P02679 FIBG_HUMAN 27 71 SEQRES 1 A 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 A 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 A 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 B 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 B 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 B 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 B 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 B 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 B 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 B 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 B 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 B 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 B 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 B 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 B 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 B 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 B 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 B 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 B 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 B 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 B 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 B 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 B 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 D 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 D 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 D 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 E 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 E 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 E 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 E 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 E 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 E 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 E 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 E 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 E 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 E 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 E 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 E 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 E 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 E 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 E 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 E 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 E 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 E 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 E 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 E 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 G 57 GLY PRO ARG VAL VAL GLU ARG HIS GLN SER ALA CYS LYS SEQRES 2 G 57 ASP SER ASP TRP PRO PHE CYS SER ASP GLU ASP TRP ASN SEQRES 3 G 57 TYR LYS CYS PRO SER GLY CYS ARG MET LYS GLY LEU ILE SEQRES 4 G 57 ASP GLU VAL ASN GLN ASP PHE THR ASN ARG ILE ASN LYS SEQRES 5 G 57 LEU LYS ASN SER LEU SEQRES 1 H 91 GLY HIS ARG PRO LEU ASP LYS LYS ARG GLU GLU ALA PRO SEQRES 2 H 91 SER LEU ARG PRO ALA PRO PRO PRO ILE SER GLY GLY GLY SEQRES 3 H 91 TYR ARG ALA ARG PRO ALA LYS ALA ALA ALA THR GLN LYS SEQRES 4 H 91 LYS VAL GLU ARG LYS ALA PRO ASP ALA GLY GLY CYS LEU SEQRES 5 H 91 HIS ALA ASP PRO ASP LEU GLY VAL LEU CYS PRO THR GLY SEQRES 6 H 91 CYS GLN LEU GLN GLU ALA LEU LEU GLN GLN GLU ARG PRO SEQRES 7 H 91 ILE ARG ASN SER VAL ASP GLU LEU ASN ASN ASN VAL GLU SEQRES 1 I 45 TYR VAL ALA THR ARG ASP ASN CYS CYS ILE LEU ASP GLU SEQRES 2 I 45 ARG PHE GLY SER TYR CYS PRO THR THR CYS GLY ILE ALA SEQRES 3 I 45 ASP PHE LEU SER THR TYR GLN THR LYS VAL ASP LYS ASP SEQRES 4 I 45 LEU GLN SER LEU GLU ASP SEQRES 1 J 57 GLY PRO ARG VAL VAL GLU ARG HIS GLN SER ALA CYS LYS SEQRES 2 J 57 ASP SER ASP TRP PRO PHE CYS SER ASP GLU ASP TRP ASN SEQRES 3 J 57 TYR LYS CYS PRO SER GLY CYS ARG MET LYS GLY LEU ILE SEQRES 4 J 57 ASP GLU VAL ASN GLN ASP PHE THR ASN ARG ILE ASN LYS SEQRES 5 J 57 LEU LYS ASN SER LEU SEQRES 1 K 91 GLY HIS ARG PRO LEU ASP LYS LYS ARG GLU GLU ALA PRO SEQRES 2 K 91 SER LEU ARG PRO ALA PRO PRO PRO ILE SER GLY GLY GLY SEQRES 3 K 91 TYR ARG ALA ARG PRO ALA LYS ALA ALA ALA THR GLN LYS SEQRES 4 K 91 LYS VAL GLU ARG LYS ALA PRO ASP ALA GLY GLY CYS LEU SEQRES 5 K 91 HIS ALA ASP PRO ASP LEU GLY VAL LEU CYS PRO THR GLY SEQRES 6 K 91 CYS GLN LEU GLN GLU ALA LEU LEU GLN GLN GLU ARG PRO SEQRES 7 K 91 ILE ARG ASN SER VAL ASP GLU LEU ASN ASN ASN VAL GLU SEQRES 1 L 45 TYR VAL ALA THR ARG ASP ASN CYS CYS ILE LEU ASP GLU SEQRES 2 L 45 ARG PHE GLY SER TYR CYS PRO THR THR CYS GLY ILE ALA SEQRES 3 L 45 ASP PHE LEU SER THR TYR GLN THR LYS VAL ASP LYS ASP SEQRES 4 L 45 LEU GLN SER LEU GLU ASP HET 0G6 B 1 30 HET PO4 B 248 5 HET 0G6 E 1 30 HET PO4 E 2 5 HETNAM 0G6 D-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO) HETNAM 2 0G6 METHYL]AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L- HETNAM 3 0G6 PROLINAMIDE HETNAM PO4 PHOSPHATE ION HETSYN 0G6 PPACK FORMUL 11 0G6 2(C21 H34 CL N6 O3 1+) FORMUL 12 PO4 2(O4 P 3-) HELIX 1 1 GLU A 14C TYR A 14J 1 8 HELIX 2 2 ALA B 55 LEU B 59 5 5 HELIX 3 3 THR B 60I ASN B 62 5 3 HELIX 4 4 ASP B 125 LEU B 130 1 9 HELIX 5 5 GLU B 164 THR B 172 1 9 HELIX 6 6 VAL B 231 ARG B 233 5 3 HELIX 7 7 LEU B 234 GLY B 246 1 13 HELIX 8 8 GLU D 14C SER D 14I 1 7 HELIX 9 9 ALA E 55 LEU E 60 1 6 HELIX 10 10 TYR E 60A ASP E 60E 5 5 HELIX 11 11 THR E 60I ASN E 62 5 3 HELIX 12 12 ASN E 95 LEU E 99 1 6 HELIX 13 13 ASP E 125 LEU E 130 1 9 HELIX 14 14 GLU E 164 SER E 171 1 8 HELIX 15 15 HIS E 230 ASP E 243 1 14 HELIX 16 16 SER G 47 LEU G 73 1 27 HELIX 17 17 THR H 78 GLU H 105 1 28 HELIX 18 18 THR I 21 ASP I 45 1 25 HELIX 19 19 SER J 47 LEU J 73 1 27 HELIX 20 20 THR K 78 GLU K 105 1 28 HELIX 21 21 ASP L 12 GLY L 16 5 5 HELIX 22 22 THR L 21 ASP L 45 1 25 SHEET 1 A 3 SER B 20 ASP B 21 0 SHEET 2 A 3 GLN B 156 PRO B 161 -1 O VAL B 157 N SER B 20 SHEET 3 A 3 LYS B 135 GLY B 140 -1 N GLY B 136 O LEU B 160 SHEET 1 B 4 GLU B 39 LEU B 40 0 SHEET 2 B 4 GLN B 30 ARG B 35 -1 N ARG B 35 O GLU B 39 SHEET 3 B 4 LEU B 64 ILE B 68 -1 O ARG B 67 N MET B 32 SHEET 4 B 4 LYS B 81 SER B 83 -1 O LYS B 81 N ILE B 68 SHEET 1 C 6 GLU B 39 LEU B 40 0 SHEET 2 C 6 GLN B 30 ARG B 35 -1 N ARG B 35 O GLU B 39 SHEET 3 C 6 ALA B 44 SER B 48 -1 O ALA B 44 N VAL B 31 SHEET 4 C 6 TRP B 51 THR B 54 -1 O LEU B 53 N SER B 45 SHEET 5 C 6 ALA B 104 LYS B 107 -1 O ALA B 104 N THR B 54 SHEET 6 C 6 ILE B 88 ILE B 90 -1 N TYR B 89 O LEU B 105 SHEET 1 D 2 PHE B 199 LYS B 202 0 SHEET 2 D 2 TRP B 207 GLY B 211 -1 O TYR B 208 N MET B 201 SHEET 1 E 2 VAL B 213 TRP B 215 0 SHEET 2 E 2 PHE B 227 TYR B 228 -1 O PHE B 227 N TRP B 215 SHEET 1 F 6 SER E 20 ASP E 21 0 SHEET 2 F 6 GLN E 156 LEU E 160 -1 O VAL E 157 N SER E 20 SHEET 3 F 6 GLY E 136 THR E 139 -1 N GLY E 136 O LEU E 160 SHEET 4 F 6 PHE E 199 LYS E 202 -1 O VAL E 200 N ARG E 137 SHEET 5 F 6 TRP E 207 TRP E 215 -1 O MET E 210 N PHE E 199 SHEET 6 F 6 PHE E 227 THR E 229 -1 O THR E 229 N ILE E 212 SHEET 1 G 7 LYS E 81 SER E 83 0 SHEET 2 G 7 LEU E 64 ILE E 68 -1 N ILE E 68 O LYS E 81 SHEET 3 G 7 GLN E 30 ARG E 35 -1 N PHE E 34 O LEU E 65 SHEET 4 G 7 GLU E 39 LEU E 46 -1 O GLU E 39 N ARG E 35 SHEET 5 G 7 TRP E 51 THR E 54 -1 O LEU E 53 N SER E 45 SHEET 6 G 7 ALA E 104 LYS E 107 -1 O ALA E 104 N THR E 54 SHEET 7 G 7 ILE E 88 ILE E 90 -1 N TYR E 89 O LEU E 105 SHEET 1 H 3 CYS H 65 LEU H 66 0 SHEET 2 H 3 VAL H 74 PRO H 77 -1 O LEU H 75 N CYS H 65 SHEET 3 H 3 LYS J 44 CYS J 45 -1 O CYS J 45 N CYS H 76 SHEET 1 I 2 CYS K 65 LEU K 66 0 SHEET 2 I 2 VAL K 74 LEU K 75 -1 O LEU K 75 N CYS K 65 SSBOND 1 CYS A 1 CYS B 122 1555 1555 2.02 SSBOND 2 CYS B 42 CYS B 58 1555 1555 2.02 SSBOND 3 CYS B 168 CYS B 182 1555 1555 2.03 SSBOND 4 CYS B 191 CYS B 220 1555 1555 2.04 SSBOND 5 CYS D 1 CYS E 122 1555 1555 2.03 SSBOND 6 CYS E 42 CYS E 58 1555 1555 2.02 SSBOND 7 CYS E 168 CYS E 182 1555 1555 2.04 SSBOND 8 CYS E 191 CYS E 220 1555 1555 2.03 SSBOND 9 CYS G 28 CYS J 28 1555 1555 2.03 SSBOND 10 CYS G 36 CYS K 65 1555 1555 2.03 SSBOND 11 CYS G 45 CYS I 23 1555 1555 2.03 SSBOND 12 CYS G 49 CYS H 76 1555 1555 2.03 SSBOND 13 CYS H 65 CYS J 36 1555 1555 2.03 SSBOND 14 CYS H 80 CYS I 19 1555 1555 2.02 SSBOND 15 CYS I 8 CYS L 9 1555 1555 2.04 SSBOND 16 CYS I 9 CYS L 8 1555 1555 2.02 SSBOND 17 CYS J 45 CYS L 23 1555 1555 2.02 SSBOND 18 CYS J 49 CYS K 76 1555 1555 2.03 SSBOND 19 CYS K 80 CYS L 19 1555 1555 2.03 LINK C3 0G6 B 1 NE2 HIS B 57 1555 1555 1.49 LINK C2 0G6 B 1 OG SER B 195 1555 1555 1.43 LINK C3 0G6 E 1 NE2 HIS E 57 1555 1555 1.49 LINK C2 0G6 E 1 OG SER E 195 1555 1555 1.42 CISPEP 1 SER B 36A PRO B 37 0 -1.06 CISPEP 2 SER E 36A PRO E 37 0 0.01 SITE 1 AC1 16 CYS B 42 HIS B 57 CYS B 58 TRP B 60D SITE 2 AC1 16 ASN B 98 LEU B 99 ASP B 189 ALA B 190 SITE 3 AC1 16 CYS B 191 GLU B 192 GLY B 193 SER B 195 SITE 4 AC1 16 SER B 214 TRP B 215 GLY B 216 GLY B 226 SITE 1 AC2 17 PO4 E 2 HIS E 57 CYS E 58 TYR E 60A SITE 2 AC2 17 ASN E 98 LEU E 99 ILE E 174 ALA E 190 SITE 3 AC2 17 CYS E 191 GLU E 192 GLY E 193 SER E 195 SITE 4 AC2 17 SER E 214 TRP E 215 GLY E 216 GLY E 219 SITE 5 AC2 17 CYS E 220 SITE 1 AC3 3 LEU B 41 GLY B 193 ARG D 15 SITE 1 AC4 5 0G6 E 1 LEU E 41 CYS E 42 CYS E 58 SITE 2 AC4 5 LYS E 60F CRYST1 76.263 76.263 192.452 90.00 90.00 120.00 P 31 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013113 0.007571 0.000000 0.00000 SCALE2 0.000000 0.015141 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005196 0.00000